Vimal K. Mehta
New Delhi, DL, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications
Profile of FGF23 and NTproBNP levels and their association with left ventricular hypertrophy in children and adolescents with CKD.
Journal: International urology and nephrology
Published: June 08, 2026
Early LDL-C Lowering Efficacy of High-intensity Atorvastatin and Ezetimibe Combination Compared with High-intensity Atorvastatin Alone in Acute Coronary Syndrome: The LAI EARLY ACS Study.
Journal: The Journal of the Association of Physicians of India
Published: March 12, 2026
Effect of Dapagliflozin on Indices of Atrial Myopathy in Rheumatic Heart Disease.
Journal: JACC. Asia
Published: February 08, 2026
Comparison of ASCVD Risk Prediction Models in STEMI: Insights From a South Asian Cohort.
Journal: JACC. Asia
Published: January 05, 2026
Effects of Dapagliflozin on Left Atrial Ejection Force in Heart Failure with Preserved Ejection Fraction: DAPA-Left Atrial Ejection Force Trial.
Journal: Anatolian journal of cardiology
Published: October 20, 2025
Risk Assessment Analysis of Type II Diabetes Mellitus and Dyslipidemia with Coronary Artery Stenosis Scoring: Intervention Strategies.
Journal: EJIFCC
Published: October 16, 2025
Yeo's Index for Mitral Valve Assessment during Percutaneous Transvenous Mitral Commissurotomy.
Journal: Journal of cardiovascular echography
Published: August 20, 2025
Molecular Characterization and Impact of the Genetic Variants GSTP1, LncRNA H19, TCF7L2 and HNF1A on the Risk of Coronary Artery Disease With and Without T2DM Comorbidity: A Genomic Biomarker Study.
Journal: Discovery medicine
Published: June 09, 2025
White blood cells and neutrophil-to-high density lipoprotein ratio as predictive markers of left ventricular dysfunction in heart failure.
Journal: World journal of methodology
Published: April 08, 2025
Last Updated: 09/26/2026